Cencora Inc. (COR) — Form 8-K: Current report

Cencora Inc. filed a current report detailing a restructuring of its operating model and reporting structure. Beginning in fiscal 2027, the company's reporting structure will consist of Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other. The filing includes unaudited revised summary reportable segment information for each quarter of fiscal 2026 and 2025.